A Dynamic Markov Model for Forecasting Diabetes Prevalence in the United States Through 2050

Overview

Journal Health Care Manag Sci

Specialty Health Services

Date 2003 Aug 29

PMID 12943151

Citations 39

Authors

Amanda A Honeycutt

James P Boyle

Kristine R Broglio

Theodore J Thompson

Thomas J Hoerger

Linda S Geiss

K M Venkat Narayan

Affiliations

Soon will be listed here.

Abstract

This study develops forecasts of the number of people with diagnosed diabetes and diagnosed diabetes prevalence in the United States through the year 2050. A Markov modeling framework is used to generate forecasts by age, race and ethnicity, and sex. The model forecasts the number of individuals in each of three states (diagnosed with diabetes, not diagnosed with diabetes, and death) in each year using inputs of estimated diagnosed diabetes prevalence and incidence; the relative risk of mortality from diabetes compared with no diabetes; and U.S. Census Bureau estimates of current population, live births, net migration, and the mortality rate of the general population. The projected number of people with diagnosed diabetes rises from 12.0 million in 2000 to 39.0 million in 2050, implying an increase in diagnosed diabetes prevalence from 4.4% in 2000 to 9.7% in 2050.

Citing Articles

Cardiovascular disease and risk of incident diabetes mellitus: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Missikpode C, Durazo-Arvizu R, Cooper R, OBrien M, Castaneda S, Talavera G J Diabetes. 2021; 13(12):1043-1053.

PMID: 34536057 PMC: 8942503. DOI: 10.1111/1753-0407.13224.

Dietary knowledge, attitude and practice among type 2 diabetes mellitus patients in Sudan: a hospital-based cross-sectional study.

Adam H, Elmosaad Y, Ahmed A, Khan A, Mahmud I Afr Health Sci. 2021; 21(1):32-40.

PMID: 34394278 PMC: 8356582. DOI: 10.4314/ahs.v21i1.6.

A system dynamics modelling simulation based on a cohort of hepatitis B epidemic research in east China community.

Yu Z, Deng M, Peng C, Song X, Chen Y, Zhang X Epidemiol Infect. 2019; 147:e86.

PMID: 30821223 PMC: 6518579. DOI: 10.1017/S0950268819000220.

A forecasting model of disease prevalence based on the McKendrick-von Foerster equation.

Akushevich I, Yashkin A, Kravchenko J, Fang F, Arbeev K, Sloan F Math Biosci. 2019; 311:31-38.

PMID: 30597156 PMC: 6916255. DOI: 10.1016/j.mbs.2018.12.017.

Age × stage-classified demographic analysis: a comprehensive approach.

Caswell H, de Vries C, Hartemink N, Roth G, van Daalen S Ecol Monogr. 2018; 88(4):560-584.

PMID: 30555177 PMC: 6283253. DOI: 10.1002/ecm.1306.

References

Turner C, Smith T, Fitterman L, Reilly T, Pate K, Witt M . The quality of health data obtained in a new survey of elderly Americans: a validation study of the proposed Medicare Beneficiary Health Status Registry (MBHSR). J Gerontol B Psychol Sci Soc Sci. 1997; 52B(1):S49-58. DOI: 10.1093/geronb/52b.1.s49. View

Moss S, Klein R, Klein B . Cause-specific mortality in a population-based study of diabetes. Am J Public Health. 1991; 81(9):1158-62. PMC: 1405646. DOI: 10.2105/ajph.81.9.1158. View

King H, Aubert R, Herman W . Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21(9):1414-31. DOI: 10.2337/diacare.21.9.1414. View

. Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association. Diabetes Care. 1998; 21(2):296-309. DOI: 10.2337/diacare.21.2.296. View

Lipton R, GOOD G, MIKHAILOV T, Freels S, Donoghue E . Ethnic differences in mortality from insulin-dependent diabetes mellitus among people less than 25 years of age. Pediatrics. 1999; 103(5 Pt 1):952-6. DOI: 10.1542/peds.103.5.952. View

Boyle J, Honeycutt A, Narayan K, Hoerger T, Geiss L, Chen H . Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001; 24(11):1936-40. DOI: 10.2337/diacare.24.11.1936. View

Helms R . Implications of population growth on prevalence of diabetes. A look at the future. Diabetes Care. 1992; 15 Suppl 1:6-9. DOI: 10.2337/diacare.15.1.s6. View

Tierney E, Geiss L, Engelgau M, Thompson T, Schaubert D, Shireley L . Population-based estimates of mortality associated with diabetes: use of a death certificate check box in North Dakota. Am J Public Health. 2001; 91(1):84-92. PMC: 1446514. DOI: 10.2105/ajph.91.1.84. View

Ruwaard D, Hoogenveen R, Verkleij H, Kromhout D, Casparie A, van der Veen E . Forecasting the number of diabetic patients in The Netherlands in 2005. Am J Public Health. 1993; 83(7):989-95. PMC: 1694793. DOI: 10.2105/ajph.83.7.989. View

10.

. Evaluation of National Health Interview Survey diagnostic reporting. Vital Health Stat 2. 1994; (120):1-116. View

11.

Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View

12.

OConnor P, RUSH W, Pronk N, Cherney L . Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods. Am J Manag Care. 1998; 4(3):335-42. View

13.

Gu K, Cowie C, Harris M . Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998; 21(7):1138-45. DOI: 10.2337/diacare.21.7.1138. View

14.

Dorman J, LaPorte R, Kuller L, Cruickshanks K, Orchard T, Wagener D . The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes. 1984; 33(3):271-6. DOI: 10.2337/diab.33.3.271. View